Professor Iain McNeish, Director of our Ovarian Cancer Action Research Centre, talks about the impact of understanding the role of surgery and why he thinks drugs called PARP inhibitors could improve cure rates.
The Ovarian Cancer Action Research Centre was Europe's first centre dedicated to ovarian cancer research. Help us continue to make breakthroughs by supporting our quest to make ovarian cancer a survivable disease.
Support us today at [ Ссылка ]
